Navigation Links
Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
Date:8/26/2013

(PRWEB) August 26, 2013

According to a Consumer Update released by the FDA on August 1, 2013, Tylenol and other medicines containing acetaminophen have been linked to Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). These “are the two most serious skin reactions linked in rare cases to acetaminophen” and “they usually require hospitalization and can cause death.” These reactions begin with flu-like symptoms followed by a rash. In some cases, the rash can blister and cover large areas of the body causing scarring. Dr. Sharon Hertz, a deputy director at the FDA, stated that “it is extremely important that people recognize and react quickly to the initial symptoms of these rare but serious, side effects, which are potentially fatal" (i).

The FDA reviewed its adverse events database and discovered that there had been 107 cases of SJS and TEN resulting in 67 hospitalizations and 12 deaths. Based on this evidence, the Agency is requiring all prescription medicines containing acetaminophen to add a warning about skin reactions on their labels. The Agency stated that it would work with over the counter manufacturers to get similar labels on their medicines. Accurate and uniform labeling is an important part of consumer safety but many people may not know which over the counter drugs contain acetaminophen because the name is often shortened as “APAP,” “acet,” “acetamin,” or “acetaminoph” (i).

Attorney Paul d’Oliveira stated, “Fortunately, the FDA is finally recognizing the danger of SJS and TEN among commonly used drugs like Tylenol. Unfortunately, it is alleged that some drug manufacturers do not warn about these risks on the labels of their medicines. For many years nobody questioned the safety of Tylenol but recent reports suggest that liver damage and SJS are real dangers. Our law firm is investigating the possible allegations of manufacturing defects, design defects, and failure to warn and working with lawyers who are litigating these cases.”

Side effects of Tylenol can be very serious in some cases. People who have suffered liver or SJS injuries may be entitled to compensation for medical bills, lost income, pain and suffering, scarring, disfigurement, loss of consortium, or wrongful death. d’Oliveira & Associates has been investigating the link between widely used medicines and hypersensitivity reactions like SJS and TEN. The law firm works with some of the more experienced Tylenol lawyers, who are handling these cases, and there is no legal fee until a settlement or award is obtained. To contact the firm call 1-800-992-6878 or submit a contact form online.

(i) FDA Consumer Update, August 1, 2013.
fda.gov/ForConsumers/ConsumerUpdates/ucm363010.htm

Read the full story at http://www.prweb.com/releases/2013/8/prweb11043687.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Why is traumatic brain injury increasing among the elderly?
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Experts Offer Advice After Yankee Pitchers Trampoline Injury
5. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
6. Mild traumatic brain injury may contribute to brain network dysfunction
7. Injury-Linked Deaths Vary Widely Among States
8. Most occupational injury and illness costs are paid by the government and private payers
9. Diabetes drug could be a promising therapy for traumatic brain injury
10. Brain-Injury Recovery Varies Widely Among Children
11. Traumatic brain injury the focus of American Headache Society scientific conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology: